Article
Fumarate Signaling in Cardiovascular Disease: Therapeutic Potential and Pathologic Pitfalls of DMF/MMF and FH1 Deficiency.
Journal of cardiovascular translational research - 1 Oct 2025
Zheng Xi-Long, Yin Hao
Abstract excerpt
Fumarate is increasingly recognized as a metabolic signal with dual effects in cardiovascular disease. Pharmacologic doses of dimethyl fumarate (DMF) and its metabolite monomethyl fumarate (MMF) transiently activate Nrf2 and HCAR2 pathways, offering antioxidant, anti-inflammatory, and antifibrotic benefits. These include reduced endothelial activation, macrophage foam cell formation, and vascular remodeling in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
